Elise Thoresen Sletten
Lecturer
Natalia Smaglyukova,
Elise Thoresen Sletten,
Anne Ørbo,
Georg Sager
:
Data on RT-qPCR assay of nuclear progesterone receptors (nPR), membrane progesterone receptors (mPR) and progesterone receptor membrane components (PGRMC) from human uterine endometrial tissue and cancer cells of the uterine cervix
Elise Thoresen Sletten,
Natalia Smaglyukova,
Anne Ørbo,
Georg Sager
:
Expression of nuclear progesterone receptors (nPR), membrane progesterone receptors (mPR) and progesterone receptor membrane components (PGRMC) in the human endometrium after 6 months levonorgestrel low dose intrauterine therapy,
Elise Thoresen Sletten,
Marit Arnes,
Lena Marianne Myreng Lyså,
Marthe Larsen,
Anne Ørbo
:
Significance of progesterone receptors (PR-A and PR-B) expression as predictors for relapse after successful therapy of endometrial hyperplasia: a retrospective cohort study
Elise Thoresen Sletten,
Marit Arnes,
Anne Beate Vereide,
Anne Ørbo
:
Intrauterine progestin therapy as a new approach to premalignant endometrial polyps: A prospective observational study
Elise Thoresen Sletten,
Marit Arnes,
Anne Beate Vereide,
Anne Ørbo
:
Low-dose LNG-IUS as therapy for endometrial hyperplasia. A prospective cohort pilot study
Anticancer Research 2018 DOI
Elise Thoresen Sletten,
Marit Arnes,
Lena Marianne Myreng Lyså,
Bjørn Thorvald Greve Moe,
Bjørn Straume,
Anne Ørbo
:
Prediction of relapse after therapy withdrawal in women with endometrial hyperplasia: A long-term follow-up study
Anticancer Research 2017 DOI
Elise Thoresen Sletten
:
Kan hormonspiralen forebygge livmorkreft?
2019
Elise Thoresen Sletten
:
Endometriehyperplasi og D-score. Benigne ovarialtumores.
2019
The 50 latest publications is shown on this page. See all publications in Cristin here →
